BroadSoft Inc. (BSFT) Drops 8% on February 08

Equities Staff |

BroadSoft Inc. (BSFT) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 8% to $28.62, a loss of $-2.49 per share. Starting at an opening price of $30.64 a share, the stock traded between $27.78 and $30.86 over the course of the trading day. Volume was 289,374 shares over 2,447 trades, against an average daily volume of 330,371 shares and a total float of 28.83 million.

The losses send BroadSoft Inc. down to a market cap of $825.09 million. In the last year, BroadSoft Inc. has traded between $40.90 and $26.91, and its 50-day SMA is currently $35.32 and 200-day SMA is $34.30.

BroadSoft Inc is a provider of software that enables mobile, fixed-line and cable service providers to deliver hosted, cloud-based Unified Communications, or UC, over their internet protocol, or IP, based networks.

BroadSoft Inc. is based out of Gaithersburg, MD and has some 1,189 employees. Its CEO is Michael Tessler.

For a complete fundamental analysis analysis of BroadSoft Inc., check out’s Stock Valuation Analysis report for BSFT. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…